GlobalData's Top 20 global pharmaceutical companies by market cap (year ended December 31, 2018) - GlobalData
Combined Holdings of Novartis (NVS) - Updated Daily
Novartis CEO Vasant Narasimhan: The right story for the company was to focus on R&D
Novartis plans to spin off Sandoz in October
Access principle 2: affordability - Novartis in Society Integrated Report 2021
NVS -- Is Its Stock Price A Worthy Investment? Learn More.
Novartis AG - ADR Shares Close in on 52-Week High - Market Mover | Nasdaq
Novartis CEO may struggle to rally investors to Sandoz spin-off | Reuters
Top 20 Radiopharma Companies Based on Market Cap
Novartis (NVS) Beats on Q1 Earnings, Sandoz Posts Growth | Nasdaq
Novartis allies with Voyager to develop gene therapies in $1.3bn deal
Visualizing the World's Biggest Pharmaceutical Companies
PharmaBoardroom - Novartis
Novartis (NVS) - Market capitalization
Novartis (NVS) Market Cap History Charts - Net Worth of Novartis
Novartis Shares Leap On Positive Clinical Trial Data | Entrepreneur
Novartis revenue by region 2022 | Statista
Top biotech and pharmaceutical companies market cap 2023 | Statista
Novartis - Wikipedia
Novartis in advanced talks to buy Cytokinetics- source | Reuters
Top 50 Most Valuable Companies Worldwide in 2023 – Media Avenue
Novartis (NVS) Tops Q3 Earnings, Ups Operating Income View | Nasdaq
